Accounts Receivable, after Allowance for Credit Loss, Current of Meihua International Medical Technologies Co., Ltd. from 31 Dec 2020 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Meihua International Medical Technologies Co., Ltd. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Dec 2020 to 30 Jun 2025.
  • Meihua International Medical Technologies Co., Ltd. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Jun 2025 was $86,603,995, a 4.9% increase year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Meihua International Medical Technologies Co., Ltd. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $86,603,995 +$4,043,139 +4.9% 30 Jun 2025 6-K 18 Sep 2025 2025 Q2
Q4 2024 $78,660,700 +$89,744 +0.11% 31 Dec 2024 6-K 18 Sep 2025 2025 Q2
Q2 2024 $82,560,856 +$3,508,428 +4.4% 30 Jun 2024 6-K 20 Sep 2024 2024 Q2
Q4 2023 $78,570,956 +$9,625,164 +14% 31 Dec 2023 20-F 25 Apr 2025 2024 FY
Q2 2023 $79,052,428 30 Jun 2023 6-K 02 Oct 2023 2023 Q2
Q4 2022 $68,945,792 +$1,844,495 +2.7% 31 Dec 2022 20-F 24 Apr 2024 2023 FY
Q4 2021 $67,101,297 +$21,404,961 +47% 31 Dec 2021 20-F/A 29 Aug 2023 2022 FY
Q4 2020 $45,696,336 31 Dec 2020 20-F 29 Jul 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.